| 2025 | 2024 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | 455,5 k € | ||||||||||||
| Gross margin | 398,8 k € | +15.1% | 346,4 k € | +12.2% | 308,7 k € | +2.6% | 300,8 k € | -0.4% | 302,0 k € | -1.7% | 307,1 k € | -0.6% | 309,0 k € | -3.3% | 319,6 k € | -17.6% | 387,8 k € | +18.7% | 326,6 k € | +26.6% | 258,1 k € | +22.3% | 211,1 k € | |
| EBITDA | 397,3 k € | +15.2% | 345,0 k € | +12.2% | 307,4 k € | +2.5% | 300,0 k € | -0.1% | 300,3 k € | -1.6% | 305,2 k € | -0.6% | 307,1 k € | -2.1% | 313,6 k € | -18.9% | 386,8 k € | +18.8% | 325,6 k € | +27.0% | 256,4 k € | +23.3% | 207,8 k € | |
| Operating profit | 387,1 k € | +15.3% | 335,7 k € | +12.7% | 297,8 k € | +2.6% | 290,2 k € | +11.0% | 261,5 k € | +1.1% | 258,8 k € | -0.9% | 261,0 k € | -2.3% | 267,1 k € | -22.3% | 343,7 k € | +23.5% | 278,3 k € | +33.1% | 209,0 k € | +41.3% | 147,9 k € | |
| Profit/loss | 263,2 k € | +13.4% | 232,2 k € | +12.3% | 206,8 k € | +2.6% | 201,6 k € | +18.1% | 170,7 k € | +13.5% | 150,4 k € | -11.0% | 169,0 k € | -3.5% | 175,1 k € | -20.7% | 220,7 k € | +35.7% | 162,7 k € | +21.3% | 134,1 k € | +41.9% | 94,5 k € | |
| Equity | 1,3 M € | +24.9% | 1,1 M € | -7.7% | 1,1 M € | +22.0% | 940,7 k € | +88.7% | 498,4 k € | +52.1% | 327,6 k € | +84.8% | 177,2 k € | -75.5% | 723,2 k € | +31.9% | 548,1 k € | +67.4% | 327,4 k € | +632.8% | 44,7 k € | -66.8% | 134,5 k € | |
| Total assets | 1,4 M € | -3.7% | 1,4 M € | +20.5% | 1,2 M € | +21.8% | 965,5 k € | +59.4% | 605,5 k € | +29.5% | 467,5 k € | -56.1% | 1,1 M € | +18.6% | 897,4 k € | +16.2% | 772,4 k € | +22.6% | 630,1 k € | +15.3% | 546,4 k € | +10.1% | 496,2 k € | |
| Cash | 406,3 k € | -37.4% | 649,4 k € | -41.4% | 1,1 M € | +23.3% | 899,4 k € | +64.0% | 548,5 k € | +47.0% | 373,0 k € | -59.6% | 923,8 k € | +30.0% | 710,4 k € | +14.6% | 620,0 k € | +42.7% | 434,6 k € | +39.4% | 311,7 k € | +43.8% | 216,8 k € | |
| Debts | 42,3 k € | -88.2% | 358,5 k € | +1161.9% | 28,4 k € | +14.5% | 24,8 k € | -76.8% | 107,1 k € | -23.4% | 139,9 k € | -84.2% | 887,0 k € | +409.3% | 174,1 k € | -22.4% | 224,3 k € | -25.9% | 302,6 k € | -39.7% | 501,5 k € | +39.4% | 359,7 k € | |
Private limited company profitable and well capitalised. Cash position declining (-37.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
BIOPAR is a Private limited company incorporated in 2011. Its main activity is: Other human health activities. Its registered office is in Silly.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette